International Journal of Clinical Practice

Male lower urinary tract symptoms and sildenafil
pp. 1779-1779(1)
Author: Jackson, G

Quality as well as quantity? Beyond low-density lipoprotein-cholesterol - the role of particle size
pp. 1780-1782(3)
Author: Wierzbicki, A. S.

Intervening on HDL-C: Is it possible? Does it work?
pp. 1782-1786(5)
Author: Wierzbicki, A. S.

Learning lessons from REACH
pp. 1786-1788(3)
Author: Kassianos, G. C.

If the shoe fits…footwear and patients with diabetes
pp. 1788-1790(3)
Authors: Parnés, A.

Health-related behaviours of people with diabetes and those with cardiometabolic risk factors: results from SHIELD
pp. 1791-1797(7)
Authors: Green, A. J.; Bazata, D. D.; Fox, K. M.; Grandy, S.

Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance
pp. 1798-1804(7)
Authors: Julius, U.; Dittrich, M.; Pietzsch, J.

Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective
pp. 1805-1811(7)
Authors: Roze, S.; Ferrières, J.; Bruckert, E.; Van Ganse, E.; Chapman, M. J.; Liens, D.; Renaudin, C.

Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects
pp. 1812-1818(7)
Authors: Agrawal, A. R.; Tandon, M.; Sharma, P. L.

Higher risk of ischaemic stroke associated with factor XI levels in dyslipidaemic patients
pp. 1819-1823(5)
Authors: Santamaría, A.; Oliver, A.; Borrell, M.; Belvís, R.; Martí-Fábregas, J.; Mateo, J.; Fontcuberta, J.

Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke
pp. 1824-1828(5)
Authors: Sharobeem, K. M.; Patel, J. V.; Ritch, A. E. S.; Lip, G. Y. H.; Gill, P. S.; Hughes, E. A.

Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function
pp. 1829-1833(5)
Authors: Lim, Vivien C. C.; Sum, C. F.; Chan, Edwin S. Y.; Yeoh, L. Y.; Lee, Y. M.; Lim, S. C.

LDL-apheresis: indications and clinical experience in a tertiary cardiac centre
pp. 1834-1842(9)
Authors: Archontakis, S.; Pottle, A.; Hakim, N.; Ilsley, C.; Barbir, M.

Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension
pp. 1843-1849(7)
Authors: McVary, K. T.; Kaufman, J.; Young, J. M.; Tseng, L.-J.

Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study
pp. 1850-1862(13)
Authors: Hatzichristou, D.; Haro, J. M.; Martin-Morales, A.; von Keitz, A.; Riley, A.; Bertsch, J.; Belger, M.; Wolka, A. M.; Beardsworth, A.

A randomised partially controlled trial to assess the impact of self-help vs. structured help from a continence nurse specialist in women with undiagnosed urinary problems in primary care
pp. 1863-1873(11)
Authors: Wagg, A. R.; Barron, D.; Kirby, M.; Stott, D.; Corlett, K.

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
pp. 1874-1883(10)
Authors: Morice, A. H.; Peterson, S.; Beckman, O.; Osmanliev, D.

Burden of asthma in the hospital setting: an Australian analysis
pp. 1884-1888(5)
Authors: Watson, L.; Turk, F.; Rabe, K. F.

The design, characteristics and predictors of mortality in the North of England Cellulitis Treatment Assessment (NECTA)
pp. 1889-1893(5)
Authors: Tan, R.; Newberry, D. J.; Arts, G. J.; Onwuamaegbu, M. E.

Vitamin D therapy in clinical practice. One dose does not fit all
pp. 1894-1899(6)
Author: Ryan, P. J.

Do patients with diabetes wear shoes of the correct size?
pp. 1900-1904(5)
Authors: Harrison, S. J.; Cochrane, L.; Abboud, R. J.; Leese, G. P.

HDL-c is a powerful lipid predictor of cardiovascular diseases
pp. 1905-1913(9)
Authors: Bruckert, E.; Hansel, B.

Correction of low HDL cholesterol to reduce cardiovascular risk: practical considerations relating to the therapeutic use of prolonged-release nicotinic acid (Niaspan^®)
pp. 1914-1921(8)
Authors: Vogt, A.; Kassner, U.; Hostalek, U.; Steinhagen-Thiessen, E.

Emerging oral therapies for multiple sclerosis
pp. 1922-1930(9)
Authors: Cohen, B. A.; Rieckmann, P.

Assessment and treatment of diabetic foot ulcer
pp. 1931-1938(8)
Authors: Fard, A. Shojaie; Esmaelzadeh, M.; Larijani, B.

Pachydermoperiostosis with gynecomastia and osteoporosis: a rare case with a rare presentation
pp. 1939-1940(2)
Authors: Ukinc, K.; Ersoz, H. O.; Erem, C.; Hacihasanoglu, A.; Ersoz, S.; Buran, M.

Chikungunya disease with nephritic presentation
pp. 1941-1941(1)
Authors: Solanki, B. S.; Arya, S. C.; Maheshwari, P.

The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome
pp. 1942-1948(7)
Authors: Thoenes, M.; Oguchi, A.; Nagamia, S.; Vaccari, C. S.; Hammoud, R.; Umpierrez, G. E.; Khan, B. V.

Who needs to care about small, dense low-density lipoproteins?
pp. 1949-1956(8)
Authors: Rizzo, M.; Berneis, K.

Erratum
pp. 1957-1957(1)